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ICU – Intensive care unit  
IRC – Institutional Review Committee 
NET – Neutrophil extracellular traps 
IV – Intravenous 
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Background  
Sepsis is estimated to cause 5 million deaths from 19 million cases each year making it one of 
the world’s most deadly disease. In low-income countries, such as Nepal, the mortality rate can 
be as high as 49%. This pilot study was conducted in at Tribhuvan University Teaching 
Hospital, Kathmandu, Nepal. Current treatment for sepsis consists of aggressive fluid treatment 
and broad-spectrum antibiotics. However, research has shown that addition of Vitamin C, 
Thiamine and Steroids might have a positive effect on the outcome.  
Objective 
To evaluate if a treatment protocol consisting of Vitamin C, Thiamine and Steroids has a 





Medical records of patients treated for sepsis and/or septic shock were obtained from the 
surgical and medical ICU as controls. Patients arriving to the ICU were given a treatment 
protocol consisting of Vitamin C, Thiamine and Steroids along the standard treatment. In order 
to compare outcomes, the data from patients receiving the protocol were to be compared with 
the historical controls treated conventionally.   
Results 
51 patients were included of whom four had received the treatment protocol. The mean age 
were 56.7 years. 52.9% of the patients admitted to the ICU were male. 51% of the patients were 
diagnosed with pneumonia. 43.1% of the patients did not survive.  
Conclusion 
Due to the limited amount of data in this study, no conclusions can be drawn on Vitamin C, 
Thiamine and Steroids effect on sepsis. However, previous studies have shown that early 
administration of Vitamin C, Thiamine and Steroids has a positive effect on the outcome for 
patients with sepsis and/or septic shock. For patients that has developed severe sepsis and acute 
respiratory distress syndrome, Vitamin C has no effect on SOFA score. This indicates that early 
administration of the protocol is necessary to obtain desired effect. More randomised controlled 
studies must be made to determine the role of Vitamin C in the treatment of sepsis.  




Sepsis is defined as “a life-threatening organ dysfunction due to a dysregulated host response 
to infection” [1]. It is estimated that 19 million cases of sepsis each year cause 5 million deaths 
worldwide. The mortality of sepsis and septic shock in low-income countries is estimated to 49 
percent, compared to high-income countries with a mortality of 25-30 percent [2]. This makes 
sepsis to one of the leading causes of death in the world.  
 
1.1 Setting 
This study was conducted at Tribhuvan University Teaching Hospital (TUTH) situated in 
Nepal, a country famous for its mountains and beautiful nature. Nepal is located in South Asia, 
bordering China to the north and India to the east, south and west. The country has a population 
of around 28.6 million and around 20 % of the population lives in urban areas [3, 4]. Nepal is 
one of the least developed countries in the world and in 2015 roughly a fifth (21.6%) of the 
population lived below the poverty line [5]. For a lot of people, particularly in western Nepal, 
there can be vast distances between their home and healthcare clinic [6]. People may have to 
walk several hours to get help, and while in labour or having a serious infection, this can be an 
impossible challenge.  
 
The health spending in Nepal is financed largely by out of pocket spending (47.7%). This means 
the patients pay at or after the time of health care delivery. The second largest part is 
government health spending (28.6%). The third largest part comes from development assistance 
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for health (DAH, 17.8%) which comes from development agencies such as UNICEF. Lastly is 
prepaid private spending (5.9%), constituted by non-public programs funded prior to obtaining 
healthcare (such as private insurances).  
 
TUTH is one of Nepal’s University Hospitals and was established in 1983. It has 700 beds and 
takes care of more than 2000 patients in the outpatient department every day. The surgical ICU 
at TUTH, where this study takes place, has 11 beds and treats patients in need of critical care.  
 
1.2 Host response to sepsis 
As the definition of sepsis implies, the symptoms are caused by a dysregulated immune system 
response to an underlying infection. The organs of the host are affected negatively by this 
response and begin to lose their function.  
 
The most common type of white blood cells in mammals are neutrophils, which constitutes an 
essential part of our defence against microorganisms [7]. However, neutrophils can cause 
serious damage to the organs of the body when they are activated out of proportion [8]. 
Neutrophils use several different mechanisms in the battle against microorganisms. They 
release antimicrobial peptides and lytic enzymes and produce reactive oxygen molecules before 
phagocyting the invader. Another mechanism is the formation of neutrophil extracellular traps 
(NET). These traps consist of neutrophil DNA, expelled from the nucleus, together with 
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histones and other proteins. NETs have the ability to bind and kill bacteria and fungi as some 
of the proteins including histones have bactericidal effects [7]. Unfortunately, the histones also 
have a concentration-dependent cytotoxic effect which can damage or kill the hosts epi- and 
endothelial cells [7, 8].  
 
One of the main issues in sepsis is the loss of function in the epi- and endothelium [9]. The 
endothelium is a layer of cells that line the wall of our blood- and lymphatic vessels. It has 
many functions including regulation of the vasomotor tone and cell nutrient trafficking. When 
there is a small localized infection, the endothelial cells get stimulated and in response release 
pro-inflammatory substances, recruiting leukocytes among other things. One other important 
mechanism in the endothelium is the increased permeability in the presence of TNF-alfa [10]. 
This leads to oedema in the tissue, making it easier for the immune system to reach the site of 
infection. Normally, this does not give rise to any problem. However, when there is a larger, 
systemic response from the immune system as in sepsis, the endothelium gets over stimulated 
leading to loss of fluids to the interstitial space. This results in hypovolemia and drop in blood 
pressure [9].  
 
The endothelium is not the only cell line suffering from impaired function. As mentioned 
previously, the epithelium is also affected. In the lungs, epithelium lines the alveolus creating 
a barrier between the air-filled alveolus and the capillaries. Between the epithelium of the 
alveolus and the endothelium of the capillaries lie the interstitial space. When a patient becomes 
septic, the inflammation causes protein-rich fluid to flow into the interstitial space because of 
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the dysfunctional endothelium. As the neutrophils enter the lungs and release their NETs, it 
damages or even destroys the epithelium, letting the protein-rich fluid into the alveolus. This in 
turn gives a perfusion-ventilation mismatch, arterial hypoxemia and reduced lung compliance. 
These changes result in a syndrome called Acute Respiratory Distress Syndrome (ARDS) [7, 
9, 11]. ARDS is a serious complication with a high mortality rate. A study conducted in 
Germany compared mortality for ARDS patients in the ICU at university hospitals vs non-
university hospitals. They showed a mortality at 39.3% for university hospitals vs 57.5% for 
non-university hospitals [12]. Please see table 1 below for diagnostic criteria regarding ARDS.  
 
Table 1. The Berlin definition of ARDS. 
Timing Within one week of a known clinical insult or new or worsening 
respiratory syndrome. 
Chest imaging Bilateral opacities – not fully explained by effusions, lobar/lung 
collapse, or nodules.  
Origin of oedema Respiratory failure not fully explained by cardiac failure or fluid 
overload. Need objective assessment (e.g. echocardiography) to 
exclude hydrostatic oedema in no risk factor present.  
 Mild 200 mm Hg < PaO2/FiO2 ≤ 300 mmHg with 
PEEP or CPAP ≥ 5 cmH2O 
Oxygenation Moderate 100 mm Hg < PaO2/FiO2 ≤ 200 mmHg with 
PEEP or CPAP ≥ 5 cmH2O 
 Severe PaO2/FiO2 ≤ 100 mmHg with 
PEEP or CPAP ≥ 5 cmH2O 
PEEP: Positive End-Expiratory Pressure, CPAP: Continuous Positive Airway Pressure. 
 
Not only infections in the lungs can give rise to complications such as ARDS. Sepsis with focus 
from e.g. the gut can cause damage in the lungs [13]. Many more mechanisms on both organ, 
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tissue and cellular level plays a part in the development of sepsis and septic shock but has been 
left out in this limited study.  
 
1.3 Current treatment  
The current treatment for sepsis and septic shock initially focuses on stabilising respiration 
through supplemental oxygen or – if necessary – intubation, establishing a venous access for 
resuscitation to manage hypotension and initial investigation including patient history, physical 
examination, laboratory and bacterial culture [14, 15]. Broad spectrum antibiotics targeting the 
suspected source of infection should be administrated intravenously as soon as blood has been 
drawn for cultivation. When the culture and sensitivity results are ready, a smaller spectrum 
antibiotic targeting the microorganism responsible for the infection should be used to avoid 
development of antibiotic resistance [16]. The patient’s vital parameters – for example oxygen 
saturation, pulse, blood pressure, GCS-score and temperature – is followed closely to evaluate 
the treatment and to determine of any more intervention is necessary.  
 
To evaluate the extent of the sepsis and the level of organ failure a scoring system is used called 
Sequential Organ Failure Assessment (SOFA) score. It evaluates the respiratory-, nervous- and 
cardiovascular system as well as liver- and kidney function and coagulation. Every part is 
graded from 0 to +4 based on predetermined levels, giving a minimum score of zero and a 
maximum score of 24. The definition of sepsis includes the term organ dysfunction, which is 
characterised as a change of two points or more in SOFA score [17]. This approach to use 
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changes in score instead of just looking at the predetermined level makes it possible to evaluate 
patients that suffers from chronic organ dysfunction before the onset of the infection.  
 
Table 2. SOFA-score [18] 
 
MAP: Mean Arterial Pressure 
If a patient does not respond to the initial treatment despite adequate fluid administration and 
antimicrobial regimen, there may be a need for an addition of vasopressors. Numerous studies 
have shown that Norepinephrine should be the first line of choice [19, 20]. Additionally, the 
sepsis diagnosis and the suspected focus of the infection should be re-evaluated if the treatment 
is non effective. Studies have shown that delay in the initial treatment, especially delay with 
antibiotics, increases the mortality by 4% every hour. Thus it is of utmost importance that the 




1.4 Vitamin C  
Vitamin C, also known as ascorbic acid, is an essential vitamin for humans. Most animals can 
synthesize it by themselves, but humans have unfortunately lost this ability and therefore need 
it in their diet or as a supplement. For several hundreds of years, vitamin C deficiency 
constituted a problem for humans in environments lacking sources of vitamin C. For example, 
during long sea voyages where fresh fruit and vegetables were not available, sailors developed 
symptoms of scurvy after two to three months [22]. In 1753, James Lind showed that scurvy 
could be treated with citrus fruits [23]. One of the most common symptoms of scurvy is loss of 
teeth, poor wound healing and wound reopening. As vitamin C is a catalyst for the enzyme that 
converts procollagen to collagen, in its absence, the tissue becomes unstable and gives rise to 
the previous mentioned symptoms.  
 
Vitamin C is an electron donor working as a reducing agent, capable of donating two electrons. 
It has many known functions in the body where its electron donating capability is responsible 
for all [24]. During infections as pneumonia and common cold, the level of Vitamin C in the 
bloodstream decreases [25]. It has been shown that leukocytes accumulate Vitamin C up to 50 
to 100-fold the concentration in plasma [26]. Neutrophils exposed to pathogens produce 
oxidants to kill the bacteria. They also increase their intra cellular storage of Vitamin C 10-fold, 
although it is not known why. One theory is that they accumulate Vitamin C to protect them 




Vitamin C is also crucial for production of catecholamines (Epinephrine, Norepinephrine & 
Dopamine) in the nervous system and adrenal gland. The catecholamines plays an important 
role as neurotransmitters and hormones in the body [24]. Its electron donating capabilities is 
also vital for fourteen mammal enzymes.  
 
As mentioned earlier, one of the feared complications of sepsis is ARDS. Two of the 
mechanisms that plays a part in the development of ARDS is lowered fluid clearance in the 
alveolus and destruction of the lung epithelium by neutrophils. Two studies made on the subject 
has shown that in patients with sepsis, vitamin C both increases the alveolar fluid clearance 
(AFC) [13] as well as inhibits the neutrophils NET-formation [27]. Both these mechanisms are 
important in the development of ARDS, which gives a new possible treatment option.  
 
1.5 Thiamine  
Thiamine, also known as vitamin B1, is another essential vitamin. Different configurations of 
Thiamine are involved in several processes in the body. It is crucial in the development of the 
brain and its function because of its involvement in the generation of acetylcholine. It is a 
cofactor in the pyruvate dehydrogenase complex, making it important in the cellular respiration. 
In the immune system, Thiamine regulate and activate many different types of cells and 
proteins, both direct and indirect. For example, it protects neutrophils through antioxidation and 
works as an anti-inflammatory component regulating the expression of inflammatory agents.  
These are just some examples of the vast number of processes that Thiamine is involved in.  
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If there is a deficiency of Thiamine, one can develop several different conditions. As Thiamine 
is vital for the conversion from pyruvate to acetyl coenzyme A, the cells can no longer use the 
aerobic pathway in the cell respiration and is forced to use the anaerobic pathway. This is much 
less effective and releases lactic acid that lower the pH of the patients’ blood and causes lactic 
acidosis [28].  
 
1.6 Steroids 
Cortisol, also known as hydrocortisone, is a type of glucocorticoid produced in the adrenal 
cortex. It has a wide set of functions including helping the body resist stress and inflammation 
as well as the regulation of carbohydrate, fat and protein metabolism [29]. Cortisol works 
through several mechanisms that inhibit inflammation. One of the most important mechanisms 
is the stabilization of the membrane of lysosomes, a membrane bound organelle. This makes it 
harder for the lysosomes membrane to rupture, thus preventing pro-inflammatory enzymes to 
be released [29]. Cortisol has the ability to both prevent inflammation before onset as well as 
reduce ongoing inflammation. When cortisol is administered to a patient with an inflammatory 
process such as glomerulonephritis, the inflammation almost always starts to subside within 24 
hours [29].  
 
If the adrenal cortex gets damaged or undergoes atrophy and loses its ability to produce 
corticosteroids, it can lead to development of Addison’s disease. As the adrenal gland can no 
longer produce the important glucocorticoids, the body is no longer capable to regulate the 
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metabolism making it impossible to maintain normal blood glucose level [29]. If a patient with 
Addison’s disease gets an infection or other stress-inducing events they can develop an Addison 
crisis which can be fatal.  
 
Studies conducted on the effect of steroids in sepsis showed that the administration of steroids 
has a positive effect on the 28-day mortality [30]. However, it did not have any effect on the 
transition from severe sepsis to septic shock [31].  
 
2. Aim/Specific objective/Research question 
Does the combination of Vitamin C, Thiamine and Steroids improve the outcome for patients 
with sepsis and septic shock, comparing mortality between patients receiving either the Vitamin 
C protocol or conventional treatment?  
 
3. Material and methods 
This prospective study with historical controls was conducted during eight weeks at Tribhuvan 
University Teaching Hospital, Kathmandu, Nepal. In total, 50 patients arriving to the ER with 
the diagnosis of sepsis and/or septic shock were planned to receive treatment with a Vitamin C 
protocol. Patients receiving the protocol were compared with controls previously treated with 
conventional treatment in the ICU. The protocol went on for 96 hours and included 
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administration of 1500 mg IV Vitamin C every 6th hour, 100 mg IV Thiamine every 6th hour 
and 50 mg IV Steroids every 6th hour. Data regarding gender, age, co-morbidity, length of 
hospitalisation, length of stay in ICU/medical ward, outcome (survivor, non-survivor, leave 
against medical advice, withdrawal), diagnose/pathogen, patient delay (time from onset of 
serious symptoms e.g. lowered degree of consciousness until arrival at the ER), doctor delay 
(time from ER to admittance to the ICU), use of vasopressors, fluids obtained in the ICU, use 
of antibiotics and if the patient were treated with the vitamin C protocol was collected and 
compiled in an Excel file.  
 
Due to circumstances regarding availability of vitamin C and communication in the ICU, only 
a few patients received the treatment protocol – too few to be of use in the study. Therefore, 
previous studies will be used in the discussion regarding the effectiveness of the treatment 
protocol.  
 
3.1 Data collection procedures 
Data from previous patients treated for sepsis and septic shock in the ICU were collected during 
eight weeks at TUTH. To find historical controls, the admittance book in the ICU was used. 
Medical records of patients admitted with the diagnose sepsis and/or septic shock were obtained 




3.2 Statistical methods 
Because of the lack of data obtained, no statistical calculations could be done. The data 
regarding e.g. mortality, pathogens and patient delay are all presented in figures and tables.  
 
4. Ethics 
The study aligned to the principles of the Helsinki declaration. An application to the IRC were 












5.1 Age & Gender 
 Figure 1. Age of patients admitted to the ICU at TUTH 
 
Figure 1 shows the age of the patients diagnosed with sepsis and/or septic shock that were 
admitted the ICU. As seen in the figure, the most common age was between 55-80 years. The 








Figure 2. Gender of patients admitted to the ICU at TUTH 
 
Figure 2 shows the gender distribution of patients diagnosed with sepsis and/or septic shock 






As seen in table 3, 51 patients were included in the study. Roughly half of the patients survived 
(51.0%) and 43.1% of the patients did not survive. In 5.9% of the cases, the patient left the ICU 
against medical advice.  
 
Table 3. Number of surviving patients admitted to the ICU at TUTH with sepsis and/or 
septic shock 
 Frequency Percent 
 Sa 26 51.0 
NSb 22 43.1 
LAMAc 3 5.9 











5.3 Vitamin C 
Figure 3. Outcome by Vitamin C protocol of patients admitted to the ICU at TUTH 
 
Figure 3 shows outcome with regards to if the patient received the Vitamin C protocol or not. 
As mentioned previously, only four patients received the Vitamin C protocol where one 
survived and three died. Among the patients receiving the conventional treatment 19 died and 
25 survived. Three patients left the ICU against medical advice, making it not possible to know 









Left against medical advice Non-survivor Survivor
n
Conventional treatment
Conventional + Vitamin C Protocol
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5.4 Panorama of infections 
Figure 4. Diagnoses of patients admitted to the ICU at TUTH 
 
Figure 4 shows what diagnoses were the most common in the enrolled patients. Pneumonia was 
by far the leading cause of sepsis (51%), followed by the “Other/Unknown” category (21.6%), 
which contains cases with unknown diagnosis or whom only received a diagnose that were not 




















Figure 5. Pathogens of patients admitted to the ICU at TUTH 
 
Only eight cases had any information regarding blood culture (C&S) and pathogens responsible 
for the infection. The bars represent how many cases contained data and what information was 
to be found. K. pneumoniae was the most common pathogen and was found in three cases. The 
















5.6 Patient delay 
Figure 6. Patient delay of patients admitted to the ICU at TUTH 
 
Number of days patients delayed before visiting the ER. In 32 cases there were information 
regarding delay. For the rest, the information was missing. The numbers were estimated from 
onset of more serious symptoms; e.g. lowered consciousness, anuria and vomiting. The most 















Figure 7. Vasopressors of patients admitted to the ICU at TUTH 
 
This figure describes the use of vasopressors in cases with sepsis and/or septic shock in the ICU 
at TUTH. All patients that were treated with vasopressors received Norepinephrine either alone 
or in combination with another drug. Most common was Norepinephrine (Noradrenaline) alone 

































6. Discussion  
Key findings of the present trial were that sepsis has a high mortality, 43% of the patients did 
not survive. Pneumonia is responsible for most infections, 51% of the patients admitted to the 
ICU at TUTH were diagnosed with pneumonia. Norepinephrine is by far the most common 
used vasopressor.  
 
6.1 Findings 
Due to problems regarding the availability of Vitamin C and communications in the ICU, no 
patients received treatment and could be enrolled to the study. 51 cases were collected from 
medical records of patients previously treated in the ICU, where four had received the Vitamin 
C protocol (table 3). Therefore, it not possible to make any conclusions about the effectiveness 
of the protocol and Vitamin Cs place in the treatment of sepsis.  
 
The most common diagnose among the patients admitted to the ICU at TUTH were pneumonia 
responsible for 51% of the cases (figure 4). This was followed by Urosepsis who accounted for 
5.9%, making pneumonia the single largest diagnose. Data were also collected on what 
pathogens (figure 5) were responsible for the sepsis. It shows that Klebsiella Pneumoniae were 
the most common pathogen. However, because of the low number of available cultivations, no 




Patient delay showed some interesting patterns (figure 6). The delay was estimated from the 
onset of more serious symptoms, e.g. lowered consciousness, anuria and vomiting. The data 
showed that most patients delayed one or two days before visiting the ER. One interesting 
aspect would be to analyse patterns of patient delay and wherever the patient lives inside or 
outside Kathmandu Valley. There may exist a pattern between time before visiting the ER and 
wherever the patient lives in rural or urban environment.  
 
The most common used vasopressor was Norepinephrine (figure 7). Every patient included in 
the study that received vasopressor had Norepinephrine either alone or in combination with 
another drug. As mentioned in the introduction, numerous studies have shown that 
Norepinephrine should be the first choice when treating a patient with vasopressors.  
 
6.2 Comparison 
One of the studies that has shown the most promising results was conducted by Marik et. al. in 
2017 [32]. They gave patients a Vitamin C protocol consisting of Vitamin C (1500 mg every 
6th hour for 96 hours or until discharge from ICU), Thiamine (200 mg every 12th hour for 96 
hours or until discharge from ICU) and Steroids (50mg every 6th hour for 168 hours or until 
discharge from ICU, followed by a taper over 72 hours). The protocol was initiated within 24 
hours after admittance to the ICU. 47 patients were enrolled to each group where both groups 
received antibiotics, one group received the protocol and the other placebo. The groups had no 
difference in baseline characteristic. The results showed a difference in mortality between the 
27 
 
groups where the protocol group had a mortality of 8.5% and placebo 40.4% (P < 0.001). The 
patients who died in the protocol group died of complications from their underlying disease, 
e.g. diabetes and severe heart failure. They also showed a decrease in SOFA-score after 72 
hours where the protocol group got a mean decrease of 4.8 and the placebo 0.9 (P < 0.001).  
 
Another study named CITRIS-ALI made in October 2019, had a different approach [33]. In this 
study, 167 patients were enrolled with 83 assigned to placebo and 84 received only Vitamin C 
50mg/kg every 6th hour for 96 hours. In a patient weighing 70kg, this would give a dose of 
14g/24 hours. This dose is significant higher compared to the one used by Marik et. al. Also 
note the lack of Thiamine and Steroids. To be included in the study, the patients had to meet 
certain criteria very different from the study mentioned above. They were only included if they 
met the criteria for ARDS (please see 1.2 for exact criteria) and the treatment could be started 
within 48 hours of the ARDS diagnosis. One of the primary outcomes was a modified SOFA-
score (bilirubin eliminated) to evaluate if Vitamin C had any effect on organ failure. The results 
showed no significant difference between the two groups. However, a secondary outcome 
measured the 28-day mortality where a significant difference was found between the groups. 
The Vitamin C protocol group had 29.8% mortality compared to the placebo group which had 
46.3% (P = 0.01). Interestingly, when looking at mortality and ICU graduation after 96 hours 
when the protocol was done, 19 patients in the placebo group had died compared to 4 in the 
Vitamin C group. In the Vitamin C group, 9 patients had graduated from the ICU after 96 hours, 
compared to only 1 in the placebo group. This is a remarkable finding that calls for more 
research regarding Vitamin Cs role in sepsis.  
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One mechanism that could support the results in the CITRIS-ALI study is the increased AFC 
showed in mice models by Fisher et. al. [13]. This study showed a decrease in AFC compared 
with controls when mice were injected intra peritoneal with faeces, inducing septic peritonitis. 
This lowered the expression of Aqp5, one of the key proteins in fluid transport. When the septic 
mice were injected with Vitamin C, the expression of Aqp5 increased as well as the AFC. This 
might explain the results in the CITRIL-ALI study where the patients who received Vitamin C 
had a higher number of ICU and hospital free days as they cleared out their pulmonary oedema 
quicker.  
 
Another mechanism behind the development of ARDS is the neutrophils NET formation and 
the following destruction of the epithelium in the alveolus. There is a possibility that early 
administration of Vitamin C can prevent the neutrophils from destroying the epithelium in the 
alveolus protecting the lungs from development of ARDS. This might explain the results 
obtained by Malik et. al. where they showed a significant difference in mortality between the 
groups that received Vitamin C or placebo. Indeed, there are more mechanisms involved in the 
development of ARDS that might play a bigger part.  
 
More randomized studies are on the way, one called Ascorbic Acid, Corticosteroids, and 
Thiamine in Sepsis (ACTS) [34]. This study is trying to replicate the results obtained by Malik 




According to Dr Patak, a resident in the ICU at TUTH, one of the biggest concerns when 
treating patients with sepsis is the time between the arrival to the ER and admittance to the ICU. 
Patients can wait for more than 48 hours before there is a free bed in the ICU. This makes a 
major concern for the Vitamin C aspect as it seems that early administration of the drug is 
important. More studies need to be made to evaluate the patient flow in the ER and to find out 
if there is a possibility to start the treatment protocol in the ER while the patient waits for a spot 
in the ICU.  
 
6.3 Authors Thoughts 
There seem to be a positive effect regarding Vitamin Cs effect on the outcome on sepsis. One 
of the most important aspects is the time of administration. The studies that showed positive 
results included patients that were early in the course of the sepsis. As mentioned earlier, Marik 
et al administered the Vitamin C protocol within 24 hours of the sepsis diagnosis, opposed to 
other studies that waited until patients were almost on the brink of death and then gave the 
protocol. The results from these studies could indicate that Vitamin C is best used to slow the 
course of the disease, preventing the patient from developing ARDS or other complications.  
 
I personally believe that Vitamin C could change the treatment foundation for sepsis and will 
follow the ACTS study with great interest.  
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7. Populärvetenskaplig sammanfattning 
Sepsis, tidigare kallad blodförgiftning, är en allvarlig sjukdom som drabbar 19 miljoner 
människor och orsakar fem miljoner dödsfall världen över varje år. Sepsis beror på att kroppen 
reagerar överdrivet på en infektion vilket innebär att immunförsvaret orsakar skada på de egna 
organen. Detta kan leda till att patientens blodtryck sjunker på grund av att vätska tränger ut 
från blodkärlen till vävnaden, och även till lungorna, vilket kan vara dödligt. Idag finns ingen 
definitiv bot för sepsis, istället ges vätskebehandling direkt i blodet för att höja blodtrycket i 
kombination med antibiotika som täcker ett stort antal bakterier, så kallad 
bredspektrumantibiotika. Innan antibiotika ges tas prover och blododlingar för att försöka ta 
reda på vilken bakterie som ligger bakom infektionen och vilken antibiotika den är känslig för. 
När provsvaren kommit sätts en antibiotika med smalare spektrum in i syfte att undvika 
resistensutveckling.  
 
Idag pågår intensiv forskning om nya behandlingar för sepsis. På senaste tiden har C-vitamin 
fångat forskarnas intresse. Forskning har visat att C-vitamin kan dämpa den kraftiga reaktionen 
från immunförsvaret och hjälpa till att få undan vätskan ifrån lungorna. De flesta djur kan bilda 
C-vitamin själva, människan har dock förlorat denna funktion till följd av en förändring i vårt 
DNA. Detta gör att C-vitamin är en så kallad essentiell vitamin vilket innebär den måste tillföras 




I studien har C-vitamin getts till patienter med sepsis eller septisk chock (en allvarlig form av 
sepsis med bland annat väldigt lågt blodtryck) tillsammans med Tiamin (även kallat vitamin 
B1) och steroider (även kallat kortison). Tiamin är, precis som C-vitamin, en essentiell vitamin 
som är viktig för vår ämnesomsättning samt för utvecklingen av fostrets nervsystem. Steroider 
har en kraftfull dämpande effekt på immunförsvaret och har visats ha en positiv effekt på 
utkomsten vid sepsis.  
 
Tyvärr fanns inget C-vitamin tillgängligt när studien genomfördes på intensivvårdsavdelningen 
i Kathmandu, Nepal. Data från patienter som tidigare behandlats för sepsis samlades in och 
jämfördes med andra studier som gjorts på området. Det har visats att C-vitamin har en positiv 
effekt på dödligheten i sepsis om det ges tidigt i sjukdomsförloppet och vidare under minst fyra 
dagar. Mer forskning behövs inom området och flera studier genomförs idag som kommer 
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